Atara Biotherapeutics (ATRA) FCF Margin Growth (3y) (2024 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) FCF Margin Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -63,107.00 |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 4.25 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 12,129.00 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 190,033.00 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | -1.35 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 86,497.00 |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | 10,262.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 371.00 |
| 10 | Atara Biotherapeutics | 146.20 Mn | 129.64 Mn | 439,000.00 | 503,912.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 503,912.00 |
| Mar 31, 2026 | 257,150.00 |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 117,853.00 |
| Jun 30, 2025 | 8,512.00 |
| Mar 31, 2025 | 116,266.00 |
| Dec 31, 2024 | 41,170.00 |
| Sep 30, 2024 | 116,017.00 |
| Jun 30, 2024 | 160,712.00 |
| Mar 31, 2024 | 180,275.00 |